AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.
  3. Financials
  4. EBITDA margin (%)

Oncolys BioPharma Inc.【JP:4588】

Market cap
¥67.6B
P/E ratio
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Dec 31, 2025-7,089.5+32.39%
Dec 31, 2024-5,354.9+75.11%
Dec 31, 2023-3,058+2380.21%
Dec 31, 2022-123.3-45.29%
Dec 31, 2021-225.4-57.59%
Dec 31, 2020-531.5+1263.13%
Dec 31, 2019-39-94.73%
Dec 31, 2018-739.2+57.23%
Dec 31, 2017-470.1-0.91%
Dec 31, 2016-474.4-38.44%
Dec 31, 2015-770.6-72.78%
Dec 31, 2014-2,830.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)